论文部分内容阅读
目的观察参麦注射液治疗急性肺源性心脏病(肺心病)的临床疗效。方法将急性肺心病患者90例分为观察组和对照组各45例,均接受常规治疗。观察组在常规治疗基础上,使用参麦注射液治疗。两组疗程均14d。结果观察组总有效率明显优于对照组(P<0.05)。结论参麦注射液治疗急性肺心病疗效满意,值得临床推广应用。
Objective To observe the clinical efficacy of Shenmai injection in the treatment of acute cor pulmonale (pulmonary heart disease). Methods 90 patients with acute pulmonary heart disease were divided into observation group and control group, 45 cases, all received routine treatment. Observation group on the basis of conventional treatment, the use of Shenmai injection treatment. Two courses of treatment are 14d. Results The total effective rate of the observation group was significantly better than that of the control group (P <0.05). Conclusion Shenmai injection in the treatment of acute pulmonary heart disease is satisfactory, it is worthy of clinical application.